These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 7539865)
1. c-met proto-oncogene expression in benign and malignant human prostate tissues. Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. Nakashiro K; Hayashi Y; Oyasu R Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131 [TBL] [Abstract][Full Text] [Related]
4. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c. MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502 [TBL] [Abstract][Full Text] [Related]
5. Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion. van Leenders G; van Balken B; Aalders T; Hulsbergen-van de Kaa C; Ruiter D; Schalken J Prostate; 2002 May; 51(2):98-107. PubMed ID: 11948964 [TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression. Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309 [TBL] [Abstract][Full Text] [Related]
8. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417 [TBL] [Abstract][Full Text] [Related]
9. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells. Davies G; Watkins G; Mason MD; Jiang WG Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243 [TBL] [Abstract][Full Text] [Related]
10. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium. Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925 [TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer. Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528 [TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984 [TBL] [Abstract][Full Text] [Related]
16. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589 [TBL] [Abstract][Full Text] [Related]
17. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995 [TBL] [Abstract][Full Text] [Related]
18. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Maygarden SJ; Strom S; Ware JL Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380 [TBL] [Abstract][Full Text] [Related]
19. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Hamdy FC; Autzen P; Robinson MC; Horne CH; Neal DE; Robson CN Cancer Res; 1997 Oct; 57(19):4427-31. PubMed ID: 9331107 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Fixemer T; Remberger K; Bonkhoff H Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]